 |
|
Cancer-Associated Retinopathy
Arch Ophthalmol. 1999;117:1641-1645.
Patients with systemic cancer may have a variety of ocular complaints. Most commonly these are metastases or adverse effects of therapy. Paraneoplastic syndromes, like cancer-associated retinopathy, rarely cause ophthalmic symptoms. We describe a patient with a malignant mixed müllerian tumor and cancer-associated retinopathy who had circulating serum antibodies to recoverin and cells positive for recoverin in the tumor. We discuss the typical clinical symptoms as well as the pathophysiology of this uncommon disorder.
Scott M. Goldstein, MD;
Nasreen A. Syed, MD;
Ann H. Milam, PhD;
Albert M. Maguire, MD;
Thomas J. Lawton, MD;
Charles W. Nichols, MD
From the Departments of Ophthalmology (Drs Goldstein, Syed, Milam, Maguire, and Nichols) and Pathology and Laboratory Medicine (Drs Syed and Lawton), Scheie Eye Institute and the Hospital of the University of Pennsylvania, Philadelphia.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Transient Retinal Effects of 5,6-Dimethylxanthenone-4-acetic Acid (DMXAA, ASA404), an Antitumor Vascular-Disrupting Agent in Phase I Clinical Trials
Jameson et al.
IOVS 2009;50:2553-2559.
ABSTRACT
| FULL TEXT
Management of Autoimmune Retinopathies With Immunosuppression
Ferreyra et al.
Arch Ophthalmol 2009;127:390-397.
ABSTRACT
| FULL TEXT
Paraneoplastic Syndromes Involving the Nervous System
Darnell and Posner
NEJM 2003;349:1543-1554.
FULL TEXT
Case 2-2002- A 58-Year-Old Woman with Unilateral Loss of Vision and Postmenopausal Bleeding
D'Amico and Dryja
NEJM 2002;346:189-195.
FULL TEXT
|
